财务业绩 - 公司净销售额增长27%，主要由于2023年8月网络攻击的影响[89] - 毛利率增加740个基点至45.8%，主要由于销量增加和成本节约[90] - 销售和管理费用占净销售额的比例下降400个基点，主要由于2023年第三季度网络攻击和商业纠纷仲裁决定的额外成本[92] - 广告费用占净销售额的比例下降50个基点，但金额有所增加，反映了公司持续支持品牌[93] - 研发费用占净销售额的比例下降30个基点，金额基本持平，公司继续投资产品创新和成本节约[94] - 每股摊薄净收益增长371%，主要由于销售额增加和成本节约，部分被出售Better Health VMS业务的损失和广告投资增加所抵消[96] 业务分部表现 - 健康和保健业务净销售额增长38%，分部调整后EBIT增长126%，主要由于网络攻击影响的恢复以及成本节约[98] - 家居业务净销售额增长38%，分部调整后EBIT增长1600%，主要由于网络攻击影响的恢复以及成本节约[99] - 生活方式业务净销售额增长40%，分部调整后EBIT增长247%，主要由于销售额增加[101] - 国际业务净销售额下降4%，分部调整后EBIT增长3%，主要由于阿根廷业务剥离以及网络攻击影响的恢复[102] - 公司和其他业务净销售额下降34%，分部调整后EBIT基本持平[103] 业务剥离 - 出售Better Health VMS业务产生1.18亿美元的损失[94] - 公司完成了Better Health VMS业务的剥离[104] 现金流和财务状况 - 经营活动产生的现金流增加主要由于盈利能力提高和激励性薪酬支付减少[106] - 公司维持了良好的信用评级和借款能力[111] - 公司宣布每股2.44美元的股息[119] 非GAAP调整项 - 公司管理层认为,由于Better Health VMS业务剥离相关的性质、范围和规模,将这些成本作为非GAAP调整项提供给投资者有助于了解公司运营趋势,并有利于期间比较[122] - 公司管理层认为,由于2023年8月网络攻击事件的性质、范围和规模,将这些成本和保险赔付作为非GAAP调整项提供给投资者有助于了解公司运营趋势,并有利于期间比较[122] - 公司管理层认为,由于数字能力和生产力提升投资的性质、范围和规模,这些成本被视为超出支持运营的历史正常信息技术支出水平的额外转型成本,将这些成本作为非GAAP调整项提供给投资者有助于了解公司运营趋势,并有利于期间比较[122] - 数字能力和生产力提升投资中约70%的运营成本预计将记录在销售和管理费用中,其中约70%与ERP实施相关,其余主要与配套技术实施相关[122] - 2024年9月30日和2023年9月30日三个月期间,公司分别发生约2900万美元和2700万美元的数字能力和生产力提升投资相关运营费用[123]

财务状况 - 公司总资产为 XXX 亿元 [1] - 公司总负债为 XXX 亿元 [1] - 公司净资产为 XXX 亿元 [1] - 公司资产负债率为 XX% [1] 营业收入 - 公司本期营业收入为 XXX 亿元 [2] - 公司营业收入同比增长 XX% [2] - 公司主营业务收入占营业收入的 XX% [2] 盈利能力 - 公司本期净利润为 XXX 亿元 [3] - 公司净利润同比增长 XX% [3] - 公司毛利率为 XX% [3] - 公司净利率为 XX% [3] 现金流 - 公司经营活动产生的现金流量净额为 XXX 亿元 [4] - 公司投资活动产生的现金流量净额为 XXX 亿元 [4] - 公司筹资活动产生的现金流量净额为 XXX 亿元 [4] - 公司现金及现金等价物净增加额为 XXX 亿元 [4]

Wall Street analysts forecast that Clorox (CLX) will report quarterly earnings of $1.36 per share in its upcoming release, pointing to a year-over-year increase of 177.6%. It is anticipated that revenues will amount to $1.63 billion, exhibiting an increase of 17.6% compared to the year-ago quarter.The consensus EPS estimate for the quarter has undergone a downward revision of 1% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed thei ...

The Clorox Company (CLX) is likely to register increases in the bottom and top lines when it reports first-quarter fiscal 2025 results on Oct. 30, 2024, after market close.The Zacks Consensus Estimate for revenues is pegged at $1.63 billion, indicating a rise of 17.6% from the prior-year quarter’s  figure. The consensus mark for quarterly earnings has risen by a penny in the past 30 days to $1.36 per share. The consensus mark indicates a sharp increase from earnings of 49 cents per share reported in the pri ...

Investing in reliable dividend stocks can be an excellent strategy for risk-averse investors.The stock market is riskier than bonds, a high-yield savings account, or just keeping your money in cash. But it's important to understand that some stocks are far safer than others (although never risk-free).When searching for safe stocks, some characteristics to consider are the company's industry and whether it has a business model and balance sheet that can hold up well during an economic downturn. Another facto ...

OAKLAND, Calif., Oct. 9, 2024 /PRNewswire/ -- The Clorox Company (NYSE: CLX) will issue its firstquarter fiscal year 2025 results on Oct. 30, 2024. Timing for the announcement will be as follows: 1:15 p.m. PT / 4:15 p.m. ET: Press release and prepared management remarks posted on the company's website 2 p.m. PT / 5 p.m. ET: Live Q&A audio webcast for analysts with Chair and CEO Linda Rendle and Chief Financial Officer Kevin Jacobsen Links to the webcast, press release and prepared remarks can be found at Cl ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Clorox (CLX) , which belongs to the Zacks Soap and Cleaning Materials industry. When looking at the last two reports, this consumer products maker has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 23.38%, on average, in the last two quarters. For the last reported quarter, Clorox came out with earnings of $1.82 ...

The Clorox Company (CLX) has continued its upward trajectory, with its stock remaining close to its 52-week high, driven by strong fundamentals and ongoing strategic initiatives. This impressive performance can be attributed to a solid innovation pipeline, digital transformation, and pricing and cost-saving initiatives. The Oakland-based company has experienced a remarkable surge in its stock price in the past three months. This Zacks Rank #3 (Hold) stock has gained 22.9%, comfortably outpacing the Zacks So ...

Jefferies analyst Kaumil Gajrawala upgraded Clorox Company CLX to Buy from Hold, raising the price forecast to $187 from $174. The analyst projects that Clorox will return to its former status as a company delivering peer-leading economic profit growth and returns on capital. Historically, this performance has warranted a valuation premium of 30% compared to its peers. According to the analyst, topline growth is already showing signs of improvement, and operating leverage is becoming increasingly attainable ...

Clorox receives honorary distinction for seventh time, demonstrating continued commitment to product stewardship OAKLAND, Calif., Sept. 25, 2024 /PRNewswire/ -- The Clorox Company (NYSE: CLX) was named a 2024 Safer Choice Partner of the Year award winner for its outstanding achievement in the manufacturing of products with ingredients that the Environmental Protection Agency (EPA) designates as safer for families, pets, workplaces, communities, and the environment. This is the company's seventh time receivi ...